Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study

  • days left to enroll
  • participants needed
  • sponsor
    University of Leipzig
Updated on 22 January 2021
vascular endothelial growth factor
macular edema
venous occlusion
retinal vein occlusion
diabetic macular edema
anti-vegf therapy
optical coherence tomography
spectral domain optical coherence tomography
visual loss


This study aims to evaluate the influence and prognostic value of systemic factors (such as the cardiovascular and metabolic status) on the treatment response to anti-VEGF therapy in macular edema due to diabetes or retinal vein occlusion.


This study includes patients with macular edema (ME) due to diabetes or retinal vein occlusion in the need of treatment.

At baseline patients underwent an extensive ophthalmological examination (best-corrected visual acuity, OCT, OCT-angiography, fluorescein angiography, fundus photography). Besides that, systemic work-up (including 24h blood pressure measurement, electrocardiogram, and serological blood testing) is conducted.

Patients underwent routine ME treatment including at least 4 monthly anti-VEGF injections, as first-line therapy. Further injections will be conducted if needed. Re-treatment criteria are: persistent intra- and/or subretinal fluid seen on SD-OCT, central subfield thickness > 300 m. Ophthalmological examination will be repeated at month 3, 6 and month 12. Systemic work-up will be repeated at month 6.

Primary outcome is the correlation of systemic parameters with functional and anatomical response at month 6. Secondary outcome is the correlation of systemic parameters with functional and anatomical response at month 12.

Condition Venous Thrombosis, Vascular Diseases, Macular Edema, age-related macular degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, Cystoid Macular Edema, Macular Degeneration, Deep Vein Thrombosis
Treatment Anti-VEGF
Clinical Study IdentifierNCT03762226
SponsorUniversity of Leipzig
Last Modified on22 January 2021


Yes No Not Sure

Inclusion Criteria

Age >= 18 years
Diagnosis of diabetes mellitus (type 1 or type 2) and/or retinal vein occlusion
macular edema causing visual loss, with study eye VA of 0.1 - 1.0 logMAR (20/25 - 20/200 Snellen equivalent)
macular edema defined clinically and by retinal thickness of > 300 m in the central subfield thickness (CST) with intra +/- subretinal fluid seen on spectral domain optical coherence tomography
last intravitreal treatment > 3 months ago

Exclusion Criteria

concomitant ocular disease that could cause macular edema (including choroidal neovascularization from any cause, uveitis or intraocular surgery less than 6 months ago)
any concomitant ocular or neurological condition that could affect Vision except of cataract
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note